| Literature DB >> 32268592 |
Hee-Tae Roh1, Su-Youn Cho2, Wi-Young So3.
Abstract
Purpose: Regular exercise can alleviate oxidative stress related to obesity and can induce secretion of myokines that are involved in the regulation of metabolic homeostasis. There are no studies examining changes in these variables as a result of Taekwondo training intervention. We aimed to investigate the effect of Taekwondo training on oxidative stress and myokine levels in overweight and obese adolescents.Entities:
Keywords: adolescents; exercise training; myokine; obesity; oxidative stress; physical fitness; taekwondo
Year: 2020 PMID: 32268592 PMCID: PMC7177505 DOI: 10.3390/ijerph17072505
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Characteristics of the participants at baseline.
| Group | CG | EG |
|
|---|---|---|---|
| Number (boys/girls) | 10 (7/3) | 10 (7/3) | |
| Age (years) | 12.50 ± 0.53 | 12.60 ± 0.52 | 0.673 |
| School grades (unit) | 5.50 ± 0.53 | 5.60 ± 0.52 | 0.673 |
| Height (cm) | 151.96 ± 6.87 | 153.07 ± 5.78 | 0.700 |
| Weight (kg) | 54.99 ± 7.06 | 58.34 ± 7.13 | 0.305 |
| BMI (kg/m2) | 23.74 ± 1.43 | 24.91 ± 1.90 | 0.137 |
| BMI z-score | 1.44 ± 0.28 | 1.56 ± 0.33 | 0.398 |
| BMI percentile (%) | 91.60 ± 4.31 | 93.24 ± 3.97 | 0.388 |
| VO2 max (ml/kg/min) | 35.42 ± 5.20 | 36.64 ± 5.38 | 0.612 |
| Grip strength (kg) | 20.49 ± 3.41 | 20.58 ± 3.47 | 0.954 |
| Leg strength (kg) | 46.24 ± 9.70 | 46.85 ± 7.64 | 0.878 |
| Sit-and-reach (cm) | 6.11 ± 6.87 | 6.09 ± 8.35 | 0.995 |
| Sargent jump (cm) | 28.70 ± 6.55 | 28.60 ± 6.13 | 0.972 |
| Stork stand test (sec) | 42.40 ± 34.40 | 39.70 ± 33.38 | 0.861 |
| MDA (nmol/ml) | 5.20 ± 0.91 | 5.41 ± 1.40 | 0.697 |
| SOD (U/ml) | 3.59 ± 0.62 | 3.34 ± 0.45 | 0.303 |
| IL-15 (pg/ml) | 2.34 ± 0.58 | 2.25 ± 0.95 | 0.801 |
| BDNF (ng/ml) | 26.58 ± 6.10 | 25.41 ± 5.36 | 0.654 |
| Irisin (ng/ml) | 143.09 ± 30.17 | 145.81 ± 32.18 | 0.848 |
| Myostatin (ng/ml) | 1.65 ± 0.43 | 1.70 ± 0.52 | 0.825 |
Data are presented as mean ± standard deviation. CG, control group; EG, experimental group; BMI, body mass index; VO2 max, maximal oxygen uptake; MDA, malondialdehyde; SOD, superoxide dismutase; IL-15, interleukin-15; BDNF, brain-derived neurotrophic factor. p-value as determined using the independent t-test for each of the two groups at baseline.
Taekwondo training programs.
| Constitution | Main Activity | |
|---|---|---|
| Warm-up (5 min) | Stretching | |
| Main Exercise | Basal fitness training | Push-up, Sit-up, Shuttle-run, Burpee test, |
| Basic motion of Taekwondo (5 min) | Close stance, Parallel stance, Riding stance, Forward stance, Forward inflection stance, Backward inflection stance, Body punch in horse-riding stance | |
| Poomsae (10 min) | Taegeuk chapter 1–8 | |
| Kicking (10 min) | Kick (Front, Side, Round house, Downward), Step (Forward, Side, Backward), Practice mitt kicking | |
| Taekwon gymnastics | Gymnastics of Taekwondo motion to music | |
| Cool-down (5 min) | Stretching | |
Change in physique and fitness over the 16-week intervention.
| Group | CG | EG | Time × Group Interaction | |||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | F |
| |
| Height (cm) | 151.96 ± 6.87 | 152.25 ± 6.77 | 153.07 ± 5.78 | 153.83 ± 5.97 | 2.551 | 0.128 |
| Weight (kg) | 54.99 ± 7.06 | 55.34 ± 6.51 | 58.34 ± 7.13 | 55.99 ± 6.53 † | 22.446 | < 0.001 *** |
| BMI (kg/m2) | 23.74 ± 1.43 | 23.82 ± 1.42 | 24.91 ± 1.90 | 23.59 ± 1.84 † | 23.993 | < 0.001 *** |
| VO2 max (ml/kg/min) | 35.42 ± 5.20 | 35.45 ± 5.66 | 36.64 ± 5.38 | 36.46 ± 5.76 | 0.064 | 0.804 |
| Grip strength (kg) | 20.49 ± 3.41 | 20.93 ± 3.47 | 20.58 ± 3.47 | 21.08 ± 3.31 | 0.010 | 0.920 |
| Leg strength (kg) | 46.24 ± 9.70 | 46.54 ± 9.51 | 46.85 ± 7.64 | 48.79 ± 9.30 † | 5.294 | 0.034 * |
| Sit-and-reach (cm) | 6.11 ± 6.87 | 6.15 ± 6.82 | 6.09 ± 8.35 | 7.48 ± 6.94 † | 4.803 | 0.042 * |
| Sargent jump (cm) | 28.70 ± 6.55 | 29.60 ± 8.15 | 28.60 ± 6.13 | 31.80 ± 6.30 † | 5.504 | 0.031 * |
| Stork stand test (sec) | 42.40 ± 34.40 | 43.00 ± 31.53 | 39.70 ± 33.38 | 39.80 ± 23.65 | 0.015 | 0.905 |
Data are presented as mean ± standard deviation. CG, control group; EG, experimental group; BMI, body mass index; VO2 max, maximal oxygen uptake; †, Significant difference pre- and post-intervention within the group (p < 0.05); *** p < 0.001; * p < 0.05.
Change in oxidative stress biomarkers over the 16-week intervention.
| Group | CG | EG | Time × Group Interaction | |||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | F |
| |
| MDA (nmol/ml) | 5.20 ± 0.91 | 5.32 ± 0.93 | 5.41 ± 1.40 | 4.79 ± 1.21 † | 18.904 | <0.001 *** |
| SOD (U/ml) | 3.59 ± 0.62 | 3.51 ± 0.57 | 3.34 ± 0.45 | 3.46 ± 0.48 † | 15.193 | 0.001 ** |
Data are presented as mean ± standard deviation. CG, control group; EG, experimental group; MDA, malondialdehyde; SOD, superoxide dismutase; † Significant difference pre- and post-intervention within the group (p < 0.05); *** p < 0.001; ** p < 0.01.
Change in myokines over the 16-week intervention.
| Group | CG | EG | Time × Group Interaction | |||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | F |
| |
| IL-15 (pg/ml) | 2.34 ± 0.58 | 2.50 ± 0.56 | 2.25 ± 0.95 | 2.30 ± 0.78 | 0.344 | 0.565 |
| BDNF (ng/ml) | 26.58 ± 6.10 | 27.68 ± 6.50 | 25.41 ± 5.36 | 29.52 ± 5.83 † | 6.767 | 0.018 * |
| Irisin (ng/ml) | 143.09 ± 30.17 | 142.78 ± 30.71 | 145.81 ± 32.18 | 136.09 ± 28.22 † | 8.566 | 0.009 ** |
| Myostatin (ng/ml) | 1.65 ± 0.43 | 1.63 ± 0.45 | 1.70 ± 0.52 | 1.75 ± 0.35 | 0.400 | 0.535 |
Data are presented as mean ± standard deviation. CG, control group; EG, experimental group; IL-15, interleukin-15; BDNF, brain-derived neurotrophic factor; † Significant difference pre- and post-intervention within the group (p < 0.05); ** p < 0.01; * p < 0.05.